This is our Regulatory Landscape newsletter for March 2025 with our monthly insights on the evolving market for Regulatory professionals.
For the month of February there were approximately 83 new Regulatory positions posted at smaller biopharma companies in the US. This is up 2% from January but essentially flat from what we saw in February 2024.
64% of these new positions in February were in Clinical Regulatory Strategy and 14% were in CMC Regulatory, 14% were in Advertising, Promotions & Labeling, and 6% in Regulatory Operations. Roughly 51% of these roles were at Director level and above. There were nine new Regulatory VP/SVP positions posted in February.
Only 23% of the new Regulatory positions in February were listed as Onsite, 40% were posted as Remote and 37% were Hybrid (remote/onsite). 25% of the February Regulatory positions were in California, 43% were in Massachusetts, and 18% were in the NJ/NY/PA area.
There were layoffs announced at 18 biotech and pharma companies in February.
This month we are working on the following searches for our clients:
- Vice President of Regulatory Affairs – Oncology (Hybrid, Boston Area)
- Regulatory Affairs Executive Director – Ophthalmics (Hybrid, Boston area)
- Regulatory Affairs Sr Director or Exec Director – Rare Disease (Remote)
We recently conducted a survey of Regulatory Affairs professionals to see how they are feeling about their jobs and whether they are considering making a change this year. You can view those survey results here: https://dennispartners.com/market-research/heading-for-a-shakeup-regulatory-affairs-career-motivations-in-2025/
Please consider us for your Regulatory hiring or let us know if you are considering a career change soon.